164 related articles for article (PubMed ID: 14680975)
61. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).
Cavallo MG; Montali A; Monetini L; Valente L; Mariani P; Bifolco M; Sirinian MI; Antonini TM; Fioretti F; Campagna F; Verna R; Arca M
Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):262-9. PubMed ID: 16054550
[TBL] [Abstract][Full Text] [Related]
62. Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families.
Ylitalo K; Large V; Pajukanta P; Reynisdottir S; Porkka KV; Vakkilainen J; Nuotio I; Taskinen MR; Arner P
Atherosclerosis; 2000 Dec; 153(2):373-81. PubMed ID: 11164426
[TBL] [Abstract][Full Text] [Related]
63. Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Reynisdottir S; Angelin B; Langin D; Lithell H; Eriksson M; Holm C; Arner P
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2287-92. PubMed ID: 9351402
[TBL] [Abstract][Full Text] [Related]
64. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.
Groenendijk M; De Bruin TW; Dallinga-Thie GM
Atherosclerosis; 2001 Oct; 158(2):369-76. PubMed ID: 11583715
[TBL] [Abstract][Full Text] [Related]
65. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395
[TBL] [Abstract][Full Text] [Related]
66. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
67. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
[TBL] [Abstract][Full Text] [Related]
68. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity.
Voors-Pette C; de Bruin TW
Atherosclerosis; 2001 Aug; 157(2):481-9. PubMed ID: 11472750
[TBL] [Abstract][Full Text] [Related]
69. ANGPTL3 gene variants in subjects with familial combined hyperlipidemia.
Bea AM; Franco-Marín E; Marco-Benedí V; Jarauta E; Gracia-Rubio I; Cenarro A; Civeira F; Lamiquiz-Moneo I
Sci Rep; 2021 Mar; 11(1):7002. PubMed ID: 33772079
[TBL] [Abstract][Full Text] [Related]
70. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia.
Brouwers MC; Cantor RM; Kono N; Yoon JL; van der Kallen CJ; Bilderbeek-Beckers MA; van Greevenbroek MM; Lusis AJ; de Bruin TW
J Lipid Res; 2006 Dec; 47(12):2799-807. PubMed ID: 16971732
[TBL] [Abstract][Full Text] [Related]
71. Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyperlipidemia.
Eurlings PM; Van Der Kallen CJ; Geurts JM; Kouwenberg P; Boeckx WD; De Bruin TW
J Lipid Res; 2002 Jun; 43(6):930-5. PubMed ID: 12032168
[TBL] [Abstract][Full Text] [Related]
72. FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
[TBL] [Abstract][Full Text] [Related]
73. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
Keulen ET; Voors-Pette C; de Bruin TW
Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
[TBL] [Abstract][Full Text] [Related]
74. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Taskinen MR; Deeb SS; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1789-95. PubMed ID: 10894818
[TBL] [Abstract][Full Text] [Related]
75. Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia.
Ekholm M; Kahan T; Jörneskog G; Bröijersén A; Wallén NH
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):113-6. PubMed ID: 26340459
[TBL] [Abstract][Full Text] [Related]
76. Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes.
Liu ML; Ylitalo K; Vakkilainen J; Nuotio I; Valkonen M; Lahdenperä S; Viikari J; Taskinen MR
Ann Med; 2002; 34(1):48-54. PubMed ID: 12014434
[TBL] [Abstract][Full Text] [Related]
77. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
[TBL] [Abstract][Full Text] [Related]
78. Positional cloning of the combined hyperlipidemia gene Hyplip1.
Bodnar JS; Chatterjee A; Castellani LW; Ross DA; Ohmen J; Cavalcoli J; Wu C; Dains KM; Catanese J; Chu M; Sheth SS; Charugundla K; Demant P; West DB; de Jong P; Lusis AJ
Nat Genet; 2002 Jan; 30(1):110-6. PubMed ID: 11753387
[TBL] [Abstract][Full Text] [Related]
79. Novel genes for familial combined hyperlipidemia.
Aouizerat BE; Allayee H; Bodnar J; Krass KL; Peltonen L; de Bruin TW; Rotter JI; Lusis AJ
Curr Opin Lipidol; 1999 Apr; 10(2):113-22. PubMed ID: 10327279
[TBL] [Abstract][Full Text] [Related]
80. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E; Farahani N; Mardani R; Taheri F; Taghizadeh H; Gheibihayat SM
Biochem Genet; 2022 Apr; 60(2):453-481. PubMed ID: 34478023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
